Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic

Effectiveness of Different Strategies in Maintaining Target Goals of Cardiovascular Risk Factors in Patients Discharged From Cardiovascular Risk Reduction Clinic

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00358033

Enrollment

200

Registered

2006-07-28

Start date

2003-07-31

Completion date

2008-05-31

Last updated

2014-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Atherosclerosis, Diabetes, Dyslipidemia, Hypertension

Brief summary

The purpose of this study is to determine whether a combined behavioral and pharmacological intervention provided by a multidisciplinary team will further reduce LDL-C, smoking, BP and Hb-A1C in diabetic patients with A1c between 7% and 9% when compared to usual care.

Interventions

BEHAVIORALCounseling

BEHAVIORALInteractive Education

BEHAVIORALGroup Support

PROCEDUREPharmacologic case management

Provided by clinical pharmacists

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Previous enrollment in Cardiovascular Risk Reduction Clinic (CRRC) * Eligible for CRRC discharge: 1. For DM patients: * HbA1c \< 7.0 %, * BP \< 130/85 mm Hg , and * LDL \< 100 mg/dl; 2. For Non-DM patients: * BP \< 140/90 mm Hg, and * LDL \< 100 mg/dl; * Able and willing to sign informed consent.

Exclusion criteria

* Presence of conditions that might limit long-term compliance (eg, dementia, acute psychiatric decompensation within the previous 6 months, unstable psychiatric disorder); * Metastatic disease or terminal illness

Design outcomes

Primary

Measure	Time frame
The number of patients who had non-compliance to ADA target goals in smoking, LDL cholesterol, blood pressure or Hb A1c.	12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026